行政索赔数据与电子临床数据识别脓毒症及器官功能障碍的差异及其对医院结局比较的影响
该回顾性队列研究纳入2013-2014年美国193家医院430万成人就诊记录,比较行政索赔数据与电子健康记录临床数据识别脓毒症及器官功能障碍的敏感性和对结局比较的影响。以电子健康记录推导的感染(血培养和抗生素给药)合并器官功能障碍(血管升压药、机械通气、肌酐翻倍、胆红素翻倍至≥2.0 mg/dL、血小板降至<100 cells/µL或乳酸≥2.0 mmol/L)为临床标准,索赔数据识别脓毒症的敏感性中位仅30%(范围5-54%),各器官功能障碍敏感性亦低且变异大。按索赔数据归入最低脓毒症死亡率四分位的医院中,46%在改用临床数据后移至更高死亡率四分位。作者结论认为索赔数据准确性变异大限制了其用于医院间脓毒症发生率和结局比较,客观临床数据可能有助于更有意义的医院比较。
要点
- 索赔数据识别脓毒症的敏感性中位仅30%(范围5-54%),医院间变异极大,不能可靠反映真实脓毒症发生率。
- 各器官功能障碍索赔敏感性:急性肾损伤66%(26-84%)、血小板减少39%(16-60%)、肝损伤36%(29-44%)、休克66%(29-84%)。
- 索赔数据与临床数据的相关性中等:脓毒症患病率Pearson系数0.64,死亡率0.61。
- 按索赔数据处于最低脓毒症死亡率四分位的医院中,46%改用临床数据后移至更高死亡率四分位。
- 基于感染和器官功能障碍编码的隐含脓毒症标准与临床数据相比同样产生重大差异。
适用人群与场景
- 2013-2014年美国193家医院的430万成人就诊记录,为回顾性队列研究。
诊断标准与关键阈值
- 临床脓毒症定义:电子健康记录推导的疑似感染(血培养和抗生素给药)合并同期器官功能障碍(血管升压药、机械通气、肌酐翻倍、胆红素翻倍至≥2.0 mg/dL、血小板降至<100 cells/µL或乳酸≥2.0 mmol/L)。
研究设计与关键结果
- 研究类型为回顾性队列研究,样本量430万成人就诊,193家美国医院,2013-2014年。
- 索赔数据识别脓毒症的敏感性中位30%(范围5-54%),急性肾损伤66%(26-84%),血小板减少39%(16-60%),肝损伤36%(29-44%),休克66%(29-84%)。
- 索赔数据与临床数据相关性:脓毒症患病率Pearson系数0.64,死亡率0.61。
- 按索赔数据处于最低脓毒症死亡率四分位的医院中,46%改用临床数据后移至更高死亡率四分位。
- 基于感染和器官功能障碍编码的隐含脓毒症标准与临床数据相比产生重大差异。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为索赔数据准确性变异大限制了其用于比较医院脓毒症发生率和结局,客观临床数据可能有助于更有意义的医院比较。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Administrative claims data are commonly used for sepsis surveillance, research, and quality improvement. However, variations in diagnosis, documentation, and coding practices for sepsis and organ dysfunction may confound efforts to estimate sepsis rates, compare outcomes, and perform risk adjustment. We evaluated hospital variation in the sensitivity of claims data relative to clinical data from electronic health records and its impact on outcome comparisons.
DESIGN, SETTING, AND PATIENTS: Retrospective cohort study of 4.3 million adult encounters at 193 U.S. hospitals in 2013-2014.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Sepsis was defined using electronic health record-derived clinical indicators of presumed infection (blood culture draws and antibiotic administrations) and concurrent organ dysfunction (vasopressors, mechanical ventilation, doubling in creatinine, doubling in bilirubin to ≥ 2.0 mg/dL, decrease in platelets to < 100 cells/µL, or lactate ≥ 2.0 mmol/L). We compared claims for sepsis prevalence and mortality rates between both methods. All estimates were reliability adjusted to account for random variation using hierarchical logistic regression modeling. The sensitivity of hospitals' claims data was low and variable: median 30% (range, 5-54%) for sepsis, 66% (range, 26-84%) for acute kidney injury, 39% (range, 16-60%) for thrombocytopenia, 36% (range, 29-44%) for hepatic injury, and 66% (range, 29-84%) for shock. Correlation between claims and clinical data was moderate for sepsis prevalence (Pearson coefficient, 0.64) and mortality (0.61). Among hospitals in the lowest sepsis mortality quartile by claims, 46% shifted to higher mortality quartiles using clinical data. Using implicit sepsis criteria based on infection and organ dysfunction codes also yielded major differences versus clinical data.
CONCLUSIONS: Variation in the accuracy of claims data for identifying sepsis and organ dysfunction limits their use for comparing hospitals' sepsis rates and outcomes. Using objective clinical data may facilitate more meaningful hospital comparisons.
参考来源
- Rhee C, Jentzsch MS, Kadri SS, et al. Variation in Identifying Sepsis and Organ Dysfunction Using Administrative Versus Electronic Clinical Data and Impact on Hospital Outcome Comparisons. Crit Care Med. 2019. PMID: 30431493. doi:10.1097/CCM.0000000000003554
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。